comparemela.com

Latest Breaking News On - Sclerosis international federation - Page 7 : comparemela.com

Novartis presents new five-year data on disability outcomes and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis

Applications Open for 2023 Du Pré Grants Program

Deadline: 30-Jun-23 The Multiple Sclerosis International Federation (MSIF) is seeking applications for the Du Pré Grants Program that enables multiple

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.